July's Best ETFs: Pro-Biotech, or Anti-Commodity

Stock quotes in this article: DUG , TUR , DEE , AGA , DNA , AMGN , BAC  

In July, the best-performing exchange-traded funds bet either against commodities, or on biotechnology stocks.

With the sharp pullback in the price of oil to the $110 level from the $140 level, the UltraShort Oil & Gas ProShares(DUG Quote) gained 32.24% in July. The fund tracks the inverse of the Dow Jones U.S. Oil & Gas Index with 200% leverage.

The second-best performer, iShares MSCI Turkey Investible Market Index Fund(TUR Quote), added 25.23% for the month. This index fund, which began trading on March 28, is off to a good start.

Two other hot newcomers with even shorter track records focus on shorting commodities. For July, the PowerShares DB Commodity Double Short ETN(DEE Quote) is up 23.06%. Over the same period, the PowerShares DB Agriculture Double Short ETN(AGA Quote) returned 21.70%.

Most of the remaining funds on the list hold biotech stocks like Genetech(DNA Quote), Amgen(AMGN Quote) and Biogen Idec(BIIB Quote).

The best-performing of these biotechnology funds are the SPDR S&P Biotech ETF(XBI Quote) and the Biotech HOLDRs Trust(BBH Quote), appreciating 20.10% and 19.75%, respectively.

Climbing out of the abyss, the Regional Bank HOLDRs Trust(RKH Quote) halved its loss over the last year with a solid, 16.60% performance in July. Top holdings include JPMorgan Chase(JPM Quote), Wells Fargo(WFC Quote) and Bank of America(BAC Quote).

Best Performing ETFs in July
Fund (Ticker) Rating 1 Month Total Return % 3 Month Total Return % Objective
ProShares Ultra Short Oil & Gas (DUG) E 32.24 13.27 Sector - Energy/Natural Res
iShares MSCI Turkey Inv Mkt Idx (TUR) U 25.23 6.45 Non-US Equity
PowerShares DB Commodity Double Sht (DEE) U 23.06 NA Growth - Domestic
PowerShares DB Agri Double Sht (AGA) U 21.70 NA Growth - Domestic
SPDR S&P Biotech ETF (XBI) B- 20.10 25.30 Sector - Health/Biotechnology
HOLDRS Biotech (BBH) C+ 19.75 26.56 Sector - Health/Biotechnology
First Trust AMEX Biotechnology (FBT) C- 17.29 15.57 Sector - Health/Biotechnology
HOLDRS Regional Bank (RKH) D+ 16.60 -14.22 Sector - Financial Services
iShares Nasdaq Biotechnology (IBB) C+ 15.70 14.80 Sector - Health/Biotechnology
PowerShares Dynamic Biotech&Genome (PBE) C- 15.65 12.13 Sector - Health/Biotechnology
Source: TheStreet.com Ratings

For an explanation of our ratings, click here.

  • Loading Comments...
  •  

SHARE:

  • email
  • print
  • comment
  • digg
  • delicious
  • linkedin
Kevin Baker became the senior financial analyst for TSC Ratings upon the August 2006 acquisition of Weiss Ratings by TheStreet.com, covering mutual funds. He joined the Weiss Group in 1997 as a banking and brokerage analyst. In 1999, he created the Weiss Group's first ratings to gauge the level of risk in U.S. equities. Baker received a B.S. degree in management from Rensselaer Polytechnic Institute and an M.B.A. with a finance specialization from Nova Southeastern University.

Recent Comments





Connect with TheStreet

Dow Jones S&P 500 NASDAQ 10-Year Note
10,452.68 1,109.24 2,185.03 33.23
Oil *
77.76
DOWN
18.90
UP
0.38
UP
9.22
UP
0.48
10 Yr
3.32%
SPDR Gold
119.18
-0.18%
+0.03%
+0.42%
+1.47%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services